Related Experiment Video
Updated: Jan 18, 2026

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
Nonlinear Relationship Between Myeloperoxidase Levels and Helicobacter pylori Infection Risk in Chinese Adults: A
Junteng Zhou1, Qihang Kong2, Xiaojing Liu2,3
1Health Management Center, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Abstract:
Objectives: This study investigates the nonlinear association between myeloperoxidase (MPO) levels and Helicobacter pylori (H. pylori) infection risk in Chinese adults, evaluating potential modifiers and clinical implications for infection prevention. Methods: An analysis was conducted on cross-sectional data from 15,180 adults who underwent routine health examinations between January and December 2021. H. pylori infection was diagnosed using the 14C-urea breath test with a threshold of disintegrations per minute (DPM) ≥ 100. ELISA was used to measure plasma MPO levels. Nonlinear associations were assessed through logistic regression, restricted cubic splines, threshold effect analysis, and subgroup interactions. Results: The study identified a U-shaped correlation between MPO levels and the risk of H. pylori infection. Compared to the middle tertile (T2: 20.6-31 ng/mL), participants in the lowest (T1: ≤20.6 ng/mL; OR = 1.36, 95% CI: 1.24-1.49) and highest tertiles (T3: ≥31 ng/mL; OR = 1.12, 1.02-1.22) exhibited elevated infection risk after full adjustment (p < 0.001). DPM levels were notably elevated in T1 (β = 37.1, 26.66-47.57) and T3 (β = 19.27, 8.81-29.72) relative to T2 (p < 0.0001). RCS-based threshold analysis identified a nonlinear inflection at 24.0 ng/mL of MPO, where each additional 1 ng/mL of MPO below this threshold was associated with a reduced infection risk (OR = 0.959, 95% CI: 0.947-0.971), whereas levels above increased the risk (OR = 1.004, 95% CI: 1.002-1.007). This pattern aligned with H. pylori breath test values, which mirrored the U-shaped trend across MPO tertiles. Subgroup analyses revealed uniform associations between MPO and H. pylori infection risk/DPM across various factors such as age, sex, BMI, and metabolic comorbidities, with all interaction p-values exceeding 0.05. Conclusions: MPO levels exhibit a robust U-shaped association with H. pylori infection risk, independent of anthropometric and metabolic confounders. Monitoring MPO may aid in identifying individuals at bidirectional infection risk, suggesting novel insights into the inflammation-infection interplay. The study's cross-sectional design limits the ability to establish causal relationships, necessitating further longitudinal research to validate these findings and elucidate their clinical implications.
More Related Videos
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

